Von der Apotheke zum Weltmarktführer - Vetter im ... - Vetter Pharma
Von der Apotheke zum Weltmarktführer - Vetter im ... - Vetter Pharma
Von der Apotheke zum Weltmarktführer - Vetter im ... - Vetter Pharma
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
After the turn of the millennium, <strong>Vetter</strong>’s grew and changed<br />
steadily. In accordance with the pharmacist Helmut <strong>Vetter</strong>’s<br />
farsighted vision, the company went from being a contract<br />
manufacturer to a full-service provi<strong>der</strong> for innovative pharmaceutical<br />
and biotechnology companies around the globe.<br />
Even after Helmut <strong>Vetter</strong>’s death, the spirit of the foun<strong>der</strong><br />
still lives on within the entire company. In the late 1990s,<br />
while he was still at the helm, the company business managers<br />
mapped out the »Mission 2000+« based on <strong>Vetter</strong>’s visions<br />
and principles. The mission’s main objective was to develop the<br />
company into a full-service provi<strong>der</strong>. It was to become a partner<br />
to innovative pharmaceutical manufacturers from all over the<br />
world. The goal was for <strong>Vetter</strong> to offer its customers comprehensive<br />
support in the aseptic filling of their drugs into end-user<br />
friendly injection systems.<br />
Looking back at the developments in the pharmaceutical<br />
industry and at the growth of biotechnology around the turn of<br />
the millennium, this proved to be a farsighted strategic direction.<br />
From its relative infancy in the early 1990s, biotechnology<br />
spent a decade adding more and more successes to its credit and<br />
today it is one of the largest forces for growth within the industry.<br />
Biotechnologically manufactured substances have opened<br />
new doors in the treatment of such illnesses as cancer and<br />
multiple sclerosis. Because most of these are parenteral drugs –<br />
in other words they are only administered by injection – there<br />
has been a steady growth in the demand for prefilled injection<br />
systems for these substances. In setting itself up early on to provide<br />
full service in the aseptic filling of syringes and cartridges,<br />
<strong>Vetter</strong> was opt<strong>im</strong>ally prepared to profit from biotechnology’s<br />
triumphal march.<br />
76 …